Biotage’s shares now traded on the Mid Cap segment of Nasdaq OMX Nordic

As from today, Biotage AB (BIOT.ST) change segment at Nasdaq OMX Nordic, from the Small Cap Segment to the Mid Cap Segment.

 
Contact persons:

Torben Jörgensen, CEO
Tel: +46 707 490584, torben.jorgensen@biotage.com
Erika Söderberg-Johnson, CFO
Tel: +46 707 204820, erika.soderberg.johnson@biotage.com

 
About Biotage

Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage’s products are used by government authorities, academic institutions, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan and South Korea. Biotage has approx. 320 employees and had sales of 611 MSEK in 2015. Biotage is listed on the NASDAQ OMX Nordic stock exchange. Website: www.biotage.com

Tags:

About Us

Biotage offers solutions, knowledge and experience in the areas of analytical chemistry, medicinal chemistry, separation and purification. The customers include pharmaceutical and biotech companies, companies within the food industry and leading academic institutes. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 463 MSEK in 2012. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com

Subscribe

Documents & Links